£2.5M
Future Planet Capital led the round as the med-tech startup prepares for international market launches.
AB
AMLo Biosciences
AMLo Biosciences develops diagnostic tests to identify low-risk early-stage skin cancer.
£2.5MTotal raised
A Newcastle University spin-out developing prognostic tests for the early detection and risk stratification of skin cancer.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Cash, assets and headcount from AMLo Biosciences's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
Penny Lovat
Co-founder
Penny brings academic research and scientific leadership experience from Newcastle University and AMLo Biosciences.
LinkedIn
Marie Labus
CEO and Co-founder
Marie brings executive leadership and commercialisation experience in healthcare, diagnostics, and MedTech. She is a board member and fundraiser with a background in intellectual property strategy.
LinkedInJM
Jane Meany
Co-founder